目的:探讨595 nm脉冲染料激光与重组人表皮生长因子(rhEGF)治疗面部瘢痕的疗效。方法:随机选取80例面部瘢痕患者。分为对照组(n = 40,595 nm激光治疗)与研究组(n = 40,595 nm激光治疗联合rhEGF),对比两组瘢痕面积、瘢痕愈合情况及评分...目的:探讨595 nm脉冲染料激光与重组人表皮生长因子(rhEGF)治疗面部瘢痕的疗效。方法:随机选取80例面部瘢痕患者。分为对照组(n = 40,595 nm激光治疗)与研究组(n = 40,595 nm激光治疗联合rhEGF),对比两组瘢痕面积、瘢痕愈合情况及评分、满意度。结果:研究组在瘢痕面积、结痂与痂皮脱落时间、创面愈合时间、瘢痕上的评分均显著低于对照组(P Objective: To investigate the efficacy of 595 nm pulsed dye laser combined with recombinant human epidermal growth factor (rhEGF) in the treatment of facial scars. Methods: A total of 80 patients with facial scars were randomly selected and divided into a control group (n = 40, treated with 595 nm laser alone) and a study group (n = 40, treated with 595 nm laser combined with rhEGF). The scar area, scar healing status, scar score, and patient satisfaction were compared between the two groups. Results: The study group showed significantly lower scar area, shorter scab and eschar shedding time, faster wound healing time, and lower scar scores compared to the control group (P < 0.05). Additionally, patient satisfaction was significantly higher in the study group than in the control group (P < 0.05). Conclusion: The combination of 595 nm pulsed dye laser and rhEGF exhibits remarkable efficacy in the treatment of facial scars, promoting wound healing, reducing scar area, and improving facial scar conditions.展开更多
目的:研究黄金射频微针联合注射A型肉毒毒素及外涂重组人表皮生长因子(Recombinant human epidermal growth factor,rhEGF)凝胶治疗痤疮瘢痕的效果。方法:研究者筛选出苏州和常州美莱美容医院2021年7月-2022年7月接诊的面部痤疮愈后形...目的:研究黄金射频微针联合注射A型肉毒毒素及外涂重组人表皮生长因子(Recombinant human epidermal growth factor,rhEGF)凝胶治疗痤疮瘢痕的效果。方法:研究者筛选出苏州和常州美莱美容医院2021年7月-2022年7月接诊的面部痤疮愈后形成瘢痕的患者共63例,并采用随机数字表法划分为研究组(n=31)和对照组(n=32)两小组。对照组选用黄金射频微针联合外涂rhEGF凝胶作为常规治疗,而研究组则在此基础上注射A型肉毒毒素联合治疗。治疗后,比较两组痤疮瘢痕修复的临床疗效、痤疮瘢痕评估量表权重评分、各种不良反应的发生情况。结果:治疗期间对照组不良反应发生率(18.75%)高于研究组(12.9%),但差异无统计学意义(P>0.05)。治疗后,研究组患者治疗后的总有效率为90.32%,高于对照组的65.63%(P<0.05)。研究组患者治疗后的ECCA评分值小于对照组(P<0.05)。结论:A型肉毒毒素注射结合黄金射频微针及rhEGF凝胶治疗痤疮瘢痕有较高的疗效,其能在保证安全性的基础上,改善痤疮后遗症。展开更多
文摘目的:探讨595 nm脉冲染料激光与重组人表皮生长因子(rhEGF)治疗面部瘢痕的疗效。方法:随机选取80例面部瘢痕患者。分为对照组(n = 40,595 nm激光治疗)与研究组(n = 40,595 nm激光治疗联合rhEGF),对比两组瘢痕面积、瘢痕愈合情况及评分、满意度。结果:研究组在瘢痕面积、结痂与痂皮脱落时间、创面愈合时间、瘢痕上的评分均显著低于对照组(P Objective: To investigate the efficacy of 595 nm pulsed dye laser combined with recombinant human epidermal growth factor (rhEGF) in the treatment of facial scars. Methods: A total of 80 patients with facial scars were randomly selected and divided into a control group (n = 40, treated with 595 nm laser alone) and a study group (n = 40, treated with 595 nm laser combined with rhEGF). The scar area, scar healing status, scar score, and patient satisfaction were compared between the two groups. Results: The study group showed significantly lower scar area, shorter scab and eschar shedding time, faster wound healing time, and lower scar scores compared to the control group (P < 0.05). Additionally, patient satisfaction was significantly higher in the study group than in the control group (P < 0.05). Conclusion: The combination of 595 nm pulsed dye laser and rhEGF exhibits remarkable efficacy in the treatment of facial scars, promoting wound healing, reducing scar area, and improving facial scar conditions.
文摘目的:研究黄金射频微针联合注射A型肉毒毒素及外涂重组人表皮生长因子(Recombinant human epidermal growth factor,rhEGF)凝胶治疗痤疮瘢痕的效果。方法:研究者筛选出苏州和常州美莱美容医院2021年7月-2022年7月接诊的面部痤疮愈后形成瘢痕的患者共63例,并采用随机数字表法划分为研究组(n=31)和对照组(n=32)两小组。对照组选用黄金射频微针联合外涂rhEGF凝胶作为常规治疗,而研究组则在此基础上注射A型肉毒毒素联合治疗。治疗后,比较两组痤疮瘢痕修复的临床疗效、痤疮瘢痕评估量表权重评分、各种不良反应的发生情况。结果:治疗期间对照组不良反应发生率(18.75%)高于研究组(12.9%),但差异无统计学意义(P>0.05)。治疗后,研究组患者治疗后的总有效率为90.32%,高于对照组的65.63%(P<0.05)。研究组患者治疗后的ECCA评分值小于对照组(P<0.05)。结论:A型肉毒毒素注射结合黄金射频微针及rhEGF凝胶治疗痤疮瘢痕有较高的疗效,其能在保证安全性的基础上,改善痤疮后遗症。
